| Fiscal Year End | Company Status | Exempt Flag |
| July 31 | Delist | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 29/Dec/1989 | 22/Jun/1999 | Canada | | |
|
|
| Exchange Filing Office |
| Location |
| (not available) |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| *Scientific Research And Development Services
| Biotechnology company dedicated to research development & commercialization of pharmaceutical and nutraceutical products. The Company is developing a Cholesterol-lowering agen, CarioRex (TM), Phytrol (TM) and Androstendione, a steriod base material.
|
|
| *Research And Development In The Life Sciences
| The Company's objective is to promote biomedical research and develop and specialize in the commercialization of new laboratory and university technologies in the biomedical field.
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| *FMI | *Forbes Medi-Tech Inc. | TSE | DELIST |
| *FBSMF | *Forbes Medi-Tech Inc. | NASDAQ | DELIST |
| *FMI | *Forbes Medi-Tech Inc. | VSE | DELIST |
| *FMI.WT.L | *Forbes Medi-Tech Inc. special wt 17My00 | VSE | DELIST |
| *FMI.WT | *Forbes Med-Tech Inc wt 31Ja98 | VSE | DELIST |
| *FRN | *Forbes Resources Ltd | VSE | DELIST |
|
|
| Name History | From | To |
| *Forbes Medi-Tech Inc. | 9/Jul/1992 | 22/Jun/1999 |
| *Forbes Resources Ltd. | 29/Dec/1989 | 8/Jul/1992 |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 99 CFR | 3/May/1999 |
|
|
|
|
|
